Dr Martens has new majority shareholder
The company which became famous for making the iconic boots was founded by German doctor Klaus Märtens in 1947.
Image © iStock.com | kanvag
Dr Martens has announced that the Guernsey-based IngreGrsy company has acquired a 38.46 per cent stake in the British footwear producer as part of a restructuring programme within owner Permira’s buyout fund. This means that IngreGrsy has replaced Luxembourg-based IngreLux as the majority shareholder in Permira V, the global private equity fund operating under British global investment firm Permira.
The company making the iconic boots was founded by German doctor Klaus Märtens in 1947 to produce the footwear he created two years earlier to help him recuperate after a skiing accident. In 1959, British shoe manufacturer R. Griggs Group bought the rights to produce the footwear in the UK. The resulting company bore the anglicised trading name ‘Dr Martens’. Permira paid GBP 300 million (USD 380.4 million) in 2013 to buy Dr Martens from the Griggs family. Under its ownership, the manufacturer has been listed on the London Stock Exchange since January 2021.
Publishing Data
This article was originally published on page 2 of the June 2024 issue of SATRA Bulletin.
Other articles from this issue »